Literature DB >> 28749537

Sodium channels and pain: from toxins to therapies.

Fernanda C Cardoso1, Richard J Lewis1.   

Abstract

Voltage-gated sodium channels (NaV channels) are essential for the initiation and propagation of action potentials that critically influence our ability to respond to a diverse range of stimuli. Physiological and pharmacological studies have linked abnormal function of NaV channels to many human disorders, including chronic neuropathic pain. These findings, along with the description of the functional properties and expression pattern of NaV channel subtypes, are helping to uncover subtype specific roles in acute and chronic pain and revealing potential opportunities to target these with selective inhibitors. High-throughput screens and automated electrophysiology platforms have identified natural toxins as a promising group of molecules for the development of target-specific analgesics. In this review, the role of toxins in defining the contribution of NaV channels in acute and chronic pain states and their potential to be used as analgesic therapies are discussed. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28749537      PMCID: PMC5980290          DOI: 10.1111/bph.13962

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  233 in total

1.  Binding specificity of sea anemone toxins to Nav 1.1-1.6 sodium channels: unexpected contributions from differences in the IV/S3-S4 outer loop.

Authors:  Joacir Stolarz Oliveira; Elisa Redaelli; André J Zaharenko; Rita Restano Cassulini; Katsuhiro Konno; Daniel C Pimenta; José C Freitas; Jeffrey J Clare; Enzo Wanke
Journal:  J Biol Chem       Date:  2004-05-28       Impact factor: 5.157

2.  Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior.

Authors:  Birgit T Priest; Beth A Murphy; Jill A Lindia; Carmen Diaz; Catherine Abbadie; Amy M Ritter; Paul Liberator; Leslie M Iyer; Shera F Kash; Martin G Kohler; Gregory J Kaczorowski; D Euan MacIntyre; William J Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

3.  Developmental switch of the expression of ion channels in human dendritic cells.

Authors:  Emese Zsiros; Katalin Kis-Toth; Peter Hajdu; Rezso Gaspar; Joanna Bielanska; Antonio Felipe; Eva Rajnavolgyi; Gyorgy Panyi
Journal:  J Immunol       Date:  2009-09-11       Impact factor: 5.422

4.  Ciguatoxin and brevetoxins share a common receptor site on the neuronal voltage-dependent Na+ channel.

Authors:  A Lombet; J N Bidard; M Lazdunski
Journal:  FEBS Lett       Date:  1987-07-27       Impact factor: 4.124

5.  Changes in the expression of voltage-gated sodium channels Nav1.3, Nav1.7, Nav1.8, and Nav1.9 in rat trigeminal ganglia following chronic constriction injury.

Authors:  Wenhua Xu; Jun Zhang; Yuanyin Wang; Liecheng Wang; Xuxia Wang
Journal:  Neuroreport       Date:  2016-08-17       Impact factor: 1.837

6.  Leucine 18, a hydrophobic residue essential for high affinity binding of anthopleurin B to the voltage-sensitive sodium channel.

Authors:  B L Dias-Kadambi; C L Drum; D A Hanck; K M Blumenthal
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

7.  Mechanisms of melanogenesis inhibition by propafenone.

Authors:  Sungran Huh; Eunsun Jung; Jienny Lee; Kyungbaeg Roh; Ju-Duck Kim; Jongsung Lee; Deokhoon Park
Journal:  Arch Dermatol Res       Date:  2010-06-13       Impact factor: 3.017

8.  Redistribution of voltage-gated sodium channels after nerve decompression contributes to relieve neuropathic pain in chronic constriction injury.

Authors:  To-Jung Tseng; Yu-Lin Hsieh; Miau-Hwa Ko; Sung-Tsang Hsieh
Journal:  Brain Res       Date:  2014-07-16       Impact factor: 3.252

9.  Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a.

Authors:  Jennifer R Deuis; Zoltan Dekan; Joshua S Wingerd; Jennifer J Smith; Nehan R Munasinghe; Rebecca F Bhola; Wendy L Imlach; Volker Herzig; David A Armstrong; K Johan Rosengren; Frank Bosmans; Stephen G Waxman; Sulayman D Dib-Hajj; Pierre Escoubas; Michael S Minett; Macdonald J Christie; Glenn F King; Paul F Alewood; Richard J Lewis; John N Wood; Irina Vetter
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

10.  Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor.

Authors:  M Flinspach; Q Xu; A D Piekarz; R Fellows; R Hagan; A Gibbs; Y Liu; R A Neff; J Freedman; W A Eckert; M Zhou; R Bonesteel; M W Pennington; K A Eddinger; T L Yaksh; M Hunter; R V Swanson; A D Wickenden
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

View more
  26 in total

1.  Recent advances in targeting ion channels to treat chronic pain.

Authors:  Edward B Stevens; Gary J Stephens
Journal:  Br J Pharmacol       Date:  2018-06       Impact factor: 8.739

2.  From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei.

Authors:  Tânia C Gonçalves; Evelyne Benoit; Michael Kurz; Laetitia Lucarain; Sophie Fouconnier; Stéphanie Combemale; Lucie Jaquillard; Brigitte Schombert; Jean-Marie Chambard; Rachid Boukaiba; Gerhard Hessler; Andrees Bohme; Laurent Bialy; Stéphane Hourcade; Rémy Béroud; Michel De Waard; Denis Servent; Michel Partiseti
Journal:  Br J Pharmacol       Date:  2019-04-09       Impact factor: 8.739

3.  Small cyclic sodium channel inhibitors.

Authors:  Steve Peigneur; Cristina da Costa Oliveira; Flávia Cristina de Sousa Fonseca; Kirsten L McMahon; Alexander Mueller; Olivier Cheneval; Ana Cristina Nogueira Freitas; Hana Starobova; Igor Dimitri Gama Duarte; David J Craik; Irina Vetter; Maria Elena de Lima; Christina I Schroeder; Jan Tytgat
Journal:  Biochem Pharmacol       Date:  2020-10-17       Impact factor: 6.100

4.  Investigation of Binding Modes and Functional Surface of Scorpion Toxins ANEP to Sodium Channels 1.7.

Authors:  Yongbo Song; Zeyu Liu; Qi Zhang; Chunming Li; Wei Jin; Lili Liu; Jianye Zhang; Jinghai Zhang
Journal:  Toxins (Basel)       Date:  2017-11-29       Impact factor: 4.546

Review 5.  Pharmacotherapy for Neuropathic Pain: A Review.

Authors:  Diego Fornasari
Journal:  Pain Ther       Date:  2017-11-24

Review 6.  The Role of Toxins in the Pursuit for Novel Analgesics.

Authors:  Yossi Maatuf; Matan Geron; Avi Priel
Journal:  Toxins (Basel)       Date:  2019-02-23       Impact factor: 4.546

7.  Translocator protein agonist Ro5-4864 alleviates neuropathic pain and promotes remyelination in the sciatic nerve.

Authors:  Bingjie Ma; Xiaoming Liu; Xuehua Huang; Yun Ji; Tian Jin; Ke Ma
Journal:  Mol Pain       Date:  2017-12-06       Impact factor: 3.395

8.  Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.

Authors:  Bryan D Moyer; Justin K Murray; Joseph Ligutti; Kristin Andrews; Philippe Favreau; John B Jordan; Josie H Lee; Dong Liu; Jason Long; Kelvin Sham; Licheng Shi; Reto Stöcklin; Bin Wu; Ruoyuan Yin; Violeta Yu; Anruo Zou; Kaustav Biswas; Les P Miranda
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

9.  Aspartic Acid Isomerization Characterized by High Definition Mass Spectrometry Significantly Alters the Bioactivity of a Novel Toxin from Poecilotheria.

Authors:  Stephen R Johnson; Hillary G Rikli
Journal:  Toxins (Basel)       Date:  2020-03-25       Impact factor: 4.546

10.  Pioneering Study on Rhopalurus crassicauda Scorpion Venom: Isolation and Characterization of the Major Toxin and Hyaluronidase.

Authors:  Caio B Abreu; Karla C F Bordon; Felipe A Cerni; Isadora S Oliveira; Carla Balenzuela; Gabriel M Alexandre-Silva; Karina F Zoccal; Mouzarllem B Reis; Gisele A Wiezel; Steve Peigneur; Ernesto L Pinheiro-Júnior; Jan Tytgat; Tiago M Cunha; Loic Quinton; Lúcia H Faccioli; Eliane C Arantes; Umberto Zottich; Manuela B Pucca
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.